Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
One-Step Nucleic Acid Amplification (OSNA) of Sentinel Lymph Node in Early-Stage Endometrial Cancer: Spanish Multicenter Study (ENDO-OSNA).
Diestro MD, Berjón A, Zapardiel I, Yébenes L, Ruiz I, Lekuona A, Rezola M, Jaunarena I, Siegrist J, Sánchez-Pastor M, Cuadra M, Sagasta A, Guerra I, Lete LI, Roldán F, Marta CB, Boillos MJ, Cardiel MJ, López-de la Manzanara C, Relea F, Coronado PJ, Pascual A, Román MJ, Peiró G, Matute LJ, Montero B, Muruzábal JC, Guarch R, Zorrero C, Calatrava A, Ribot L, Costa I, Hernández A, Hardisson D. Diestro MD, et al. Among authors: lopez de la manzanara c. Cancers (Basel). 2021 Sep 4;13(17):4465. doi: 10.3390/cancers13174465. Cancers (Basel). 2021. PMID: 34503275 Free PMC article.
Failure of scintigraphy lymphatic mapping in endometrial cancer. Causes and solutions.
Martínez Bravo WR, García Vicente AM, Noriega Álvarez E, González García B, López-de la Manzanara C, Cordero García JM, Soriano Castrejón Á. Martínez Bravo WR, et al. Among authors: lopez de la manzanara c. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2021 Aug 19:S2253-654X(21)00059-7. doi: 10.1016/j.remn.2021.02.016. Online ahead of print. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2021. PMID: 34420892 English, Spanish.
Failure of scintigraphy lymphatic mapping in endometrial cancer. Causes and solutions.
Martínez Bravo WR, García Vicente AM, Noriega Álvarez E, González García B, López-de la Manzanara C, Cordero García JM, Soriano Castrejón Á. Martínez Bravo WR, et al. Among authors: lopez de la manzanara c. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022 Mar-Apr;41(2):78-85. doi: 10.1016/j.remnie.2021.04.004. Epub 2021 Apr 14. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022. PMID: 35292142
Paclitaxel as HIPEC-Drug after Surgical Cytoreduction for Ovarian Peritoneal Metastases: A Randomized Phase III Clinical Trial (HIPECOVA).
Villarejo Campos P, Sánchez García S, Amo-Salas M, García Santos E, López de la Manzanara C, Alberca A, Padilla-Valverde D, Redondo Calvo FJ, Martín J. Villarejo Campos P, et al. Among authors: lopez de la manzanara c. Curr Oncol. 2024 Jan 24;31(2):660-671. doi: 10.3390/curroncol31020048. Curr Oncol. 2024. PMID: 38392042 Free PMC article. Clinical Trial.
Prognostic factors in patients with uterine sarcoma: the SARCUT study.
Zapardiel I, Gracia Segovia M, Macuks R, Mancari R, Achimas-Cadariu P, Corrado G, Bartusevicius A, Sukhin V, Muruzabal JC, Coronado Martín PJ, Gardella B, Piek JM, Concin N, Arab C, Papatheodorou D, Polterauer S, Iacoponi S, Nieto T, Lopez-Sanclemente MC, Trukhan H, Gil MM, Bakinovskaya I, Dalamanava A, Cucurull M, Rovski D, Baquedano L, Chiva L, Mardas M, Mavrichev SA, Klat J, Lopez de la Manzanara CA, Yildirim Y; SARCUT Study Group. Zapardiel I, et al. Among authors: lopez de la manzanara ca. Int J Gynecol Cancer. 2023 Jun 5;33(6):897-904. doi: 10.1136/ijgc-2022-004204. Int J Gynecol Cancer. 2023. PMID: 37192761